These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 20814319

  • 1. Treatment options for bipolar depression: a systematic review of randomized, controlled trials.
    Vieta E, Locklear J, Günther O, Ekman M, Miltenburger C, Chatterton ML, Aström M, Paulsson B.
    J Clin Psychopharmacol; 2010 Oct; 30(5):579-90. PubMed ID: 20814319
    [Abstract] [Full Text] [Related]

  • 2. Cost effectiveness of adjunctive quetiapine fumarate extended-release tablets with mood stabilizers in the maintenance treatment of bipolar I disorder.
    Woodward TC, Tafesse E, Quon P, Lazarus A.
    Pharmacoeconomics; 2010 Oct; 28(9):751-64. PubMed ID: 20623994
    [Abstract] [Full Text] [Related]

  • 3. Efficacy of modern antipsychotics in placebo-controlled trials in bipolar depression: a meta-analysis.
    Cruz N, Sanchez-Moreno J, Torres F, Goikolea JM, Valentí M, Vieta E.
    Int J Neuropsychopharmacol; 2010 Feb; 13(1):5-14. PubMed ID: 19638254
    [Abstract] [Full Text] [Related]

  • 4. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I).
    Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, Paulsson B, Brecher M, EMBOLDEN I (Trial 001) Investigators.
    J Clin Psychiatry; 2010 Feb; 71(2):150-62. PubMed ID: 20122369
    [Abstract] [Full Text] [Related]

  • 5. A double-blind, placebo-controlled study of quetiapine and paroxetine as monotherapy in adults with bipolar depression (EMBOLDEN II).
    McElroy SL, Weisler RH, Chang W, Olausson B, Paulsson B, Brecher M, Agambaram V, Merideth C, Nordenhem A, Young AH, EMBOLDEN II (Trial D1447C00134) Investigators.
    J Clin Psychiatry; 2010 Feb; 71(2):163-74. PubMed ID: 20122366
    [Abstract] [Full Text] [Related]

  • 6. Quetiapine in the treatment of anxiety in patients with bipolar I or II depression: a secondary analysis from a randomized, double-blind, placebo-controlled study.
    Hirschfeld RM, Weisler RH, Raines SR, Macfadden W, BOLDER Study Group.
    J Clin Psychiatry; 2006 Mar; 67(3):355-62. PubMed ID: 16649820
    [Abstract] [Full Text] [Related]

  • 7. [Evidence of treatment for depressive episodes of bipolar disorder].
    Yamada K.
    Seishin Shinkeigaku Zasshi; 2011 Mar; 113(9):873-9. PubMed ID: 22117392
    [Abstract] [Full Text] [Related]

  • 8. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Mar; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical value of early partial symptomatic improvement in the prediction of response and remission during short-term treatment trials in 3369 subjects with bipolar I or II depression.
    Kemp DE, Ganocy SJ, Brecher M, Carlson BX, Edwards S, Eudicone JM, Evoniuk G, Jansen W, Leon AC, Minkwitz M, Pikalov A, Stassen HH, Szegedi A, Tohen M, Van Willigenburg AP, Calabrese JR.
    J Affect Disord; 2011 Apr; 130(1-2):171-9. PubMed ID: 21071096
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Balancing benefits and harms of treatments for acute bipolar depression.
    Ketter TA, Miller S, Dell'Osso B, Calabrese JR, Frye MA, Citrome L.
    J Affect Disord; 2014 Dec; 169 Suppl 1():S24-33. PubMed ID: 25533911
    [Abstract] [Full Text] [Related]

  • 15. Clinical highlights in bipolar depression: focus on atypical antipsychotics.
    Calabrese JR, Elhaj O, Gajwani P, Gao K.
    J Clin Psychiatry; 2005 Dec; 66 Suppl 5():26-33. PubMed ID: 16038599
    [Abstract] [Full Text] [Related]

  • 16. Clinical assessment of lurasidone benefit and risk in the treatment of bipolar I depression using number needed to treat, number needed to harm, and likelihood to be helped or harmed.
    Citrome L, Ketter TA, Cucchiaro J, Loebel A.
    J Affect Disord; 2014 Feb; 155():20-7. PubMed ID: 24246116
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and tolerability of atypical antipsychotics for acute bipolar depression: a network meta-analysis.
    Kadakia A, Dembek C, Heller V, Singh R, Uyei J, Hagi K, Nosaka T, Loebel A.
    BMC Psychiatry; 2021 May 11; 21(1):249. PubMed ID: 33975574
    [Abstract] [Full Text] [Related]

  • 18. Olanzapine/fluoxetine combination for the treatment of mixed depression in bipolar I disorder: a post hoc analysis.
    Benazzi F, Berk M, Frye MA, Wang W, Barraco A, Tohen M.
    J Clin Psychiatry; 2009 Oct 11; 70(10):1424-31. PubMed ID: 19906346
    [Abstract] [Full Text] [Related]

  • 19. Treatment of bipolar depression: making sensible decisions.
    Citrome L.
    CNS Spectr; 2014 Dec 11; 19 Suppl 1():4-11; quiz 1-3, 12. PubMed ID: 25407667
    [Abstract] [Full Text] [Related]

  • 20. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Dec 11; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.